His primary areas of study are Surgery, Hepatectomy, Chemotherapy, Radiology and Internal medicine. His Surgery study frequently links to other fields, such as Pancreatic cancer. The concepts of his Hepatectomy study are interwoven with issues in Cancer, Preoperative care, Survival rate, Rectum and Radiofrequency ablation.
His Survival rate research is multidisciplinary, incorporating perspectives in Stage and Surgical margin. His work carried out in the field of Chemotherapy brings together such families of science as Metastasis and Oxaliplatin. His studies in Internal medicine integrate themes in fields like Gastroenterology, Oncology and Pathology.
Eddie K. Abdalla mainly investigates Surgery, Internal medicine, Hepatectomy, Radiology and Hepatocellular carcinoma. His Surgery research focuses on Colorectal cancer and how it connects with Asymptomatic. Eddie K. Abdalla interconnects Gastroenterology and Oncology in the investigation of issues within Internal medicine.
His Hepatectomy research includes themes of Survival rate, Oxaliplatin, Retrospective cohort study, Radiofrequency ablation and Metastasis. The various areas that he examines in his Radiology study include Liver function, Portal vein embolization and Hepatic resection. His Hepatocellular carcinoma research is multidisciplinary, incorporating elements of Liver transplantation, Transplantation, Cirrhosis, Liver disease and Carcinoma.
His scientific interests lie mostly in Surgery, Internal medicine, Hepatectomy, Oncology and Survival rate. His Surgery research includes elements of Colorectal cancer and Radiofrequency ablation. The Internal medicine study combines topics in areas such as Gastroenterology and Lymph.
The Hepatectomy study which covers Mortality rate that intersects with Primary tumor and Thyroid. His study in Oncology is interdisciplinary in nature, drawing from both Neoadjuvant therapy, Cancer, Metastasis, Estrogen Receptor Status and Multivariate analysis. The study incorporates disciplines such as Regimen, Irinotecan and Oxaliplatin in addition to Chemotherapy.
His primary scientific interests are in Neoadjuvant therapy, Internal medicine, Surgery, Oncology and Hepatectomy. His studies deal with areas such as Stage, Pancreatic cancer, Retrospective cohort study and Adenocarcinoma as well as Neoadjuvant therapy. His biological study focuses on Hazard ratio.
His specific area of interest is Surgery, where Eddie K. Abdalla studies Survival rate. His Survival rate research incorporates themes from Liver cancer, Colorectal cancer, Cirrhosis and Prospective cohort study. His research in Hepatectomy tackles topics such as Proportional hazards model which are related to areas like Odds ratio, Young adult, Chemoprophylaxis, Fibrinolytic agent and Blood transfusion.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
James C. Yao;Manal Hassan;Alexandria T. Phan;Cecile Dagohoy.
Journal of Clinical Oncology (2008)
Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases
Eddie K. Abdalla;Jean-Nicolas Vauthey;Lee M. Ellis;Vickie Ellis.
Annals of Surgery (2004)
The international position on laparoscopic liver surgery: The Louisville Statement, 2008.
Joseph F. Buell;Daniel Cherqui;David A. Geller;Nicholas O'Rourke.
Annals of Surgery (2009)
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
Jean Nicolas Vauthey;Timothy M. Pawlik;Dario Ribero;Tsung Teh Wu.
Journal of Clinical Oncology (2006)
Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases
Timothy M. Pawlik;Charles R. Scoggins;Daria Zorzi;Eddie K. Abdalla.
Annals of Surgery (2005)
Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.
Matthew H.G. Katz;Peter W.T. Pisters;Douglas B. Evans;Charlotte C. Sun.
Journal of The American College of Surgeons (2008)
Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases
Dan G. Blazer;Yoji Kishi;Dipen M. Maru;Scott Kopetz.
Journal of Clinical Oncology (2008)
Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement
Eddie K. Abdalla;René Adam;Anton J. Bilchik;Daniel Jaeck.
Annals of Surgical Oncology (2006)
Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization.
Eddie K. Abdalla;Carlton C. Barnett;Dorota Doherty;Steven A. Curley.
Archives of Surgery (2002)
Pancreaticoduodenectomy with vascular resection: margin status and survival duration
Jennifer F. Tseng;Chandrajit P. Raut;Jeffrey E. Lee;Peter W.T. Pisters.
Journal of Gastrointestinal Surgery (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: